[HTML][HTML] Treatment strategies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond

Y Saito, K Oyama, K Tsujita, S Yasuda, Y Kobayashi - Journal of cardiology, 2023 - Elsevier
Owing to recent advances in early reperfusion strategies, pharmacological therapy,
standardized care, and the identification of vulnerable patient subsets, the prognosis of …

Complete percutaneous coronary revascularization in acute coronary syndromes with multivessel coronary disease: a systematic review

DC Faro, C Laudani, FG Agnello, N Ammirabile… - Cardiovascular …, 2023 - jacc.org
Multivessel disease (MVD) affects approximately 50% of patients with acute coronary
syndromes (ACS) and is significantly burdened by poor outcomes and high mortality. It …

[HTML][HTML] Management of residual risk in chronic coronary syndromes. Clinical pathways for a quality-based secondary prevention

S Giubilato, F Lucà, MG Abrignani, L Gatto… - Journal of Clinical …, 2023 - mdpi.com
Chronic coronary syndrome (CCS), which encompasses a broad spectrum of clinical
presentations of coronary artery disease (CAD), is the leading cause of morbidity and …

Screening for atrial fibrillation in the elderly: a network meta-analysis of randomized trials

A Elbadawi, R Sedhom, M Gad, M Hamed… - European Journal of …, 2022 - Elsevier
Abstract Background Randomized controlled trials (RCTs) investigating the optimal
screening strategy for atrial fibrillation (AF) have yielded conflicting results. Objective To …

[HTML][HTML] Complete revascularization in acute myocardial infarction: a clinical review

Y Saito, Y Kobayashi - Cardiovascular Intervention and Therapeutics, 2023 - Springer
In patients with ST segment elevation and non-ST elevation myocardial infarction (MI),
multivessel (MV) coronary artery disease is found in approximately 50%, leading to worse …

Fractional flow reserve versus angiography alone in guiding myocardial revascularisation: a systematic review and meta-analysis of randomised trials

A Elbadawi, R Sedhom, AT Dang, MM Gad, F Rahman… - Heart, 2022 - heart.bmj.com
Background Randomised trials evaluating the efficacy and safety of fractional flow reserve
(FFR)-guided versus angiography-guided revascularisation among patients with obstructive …

[HTML][HTML] The optimal timing for non-culprit percutaneous coronary intervention in patients with multivessel coronary artery disease: a pairwise and network meta …

Y Feng, S Li, S Hu, J Wan, H Shao - Frontiers in Cardiovascular …, 2022 - frontiersin.org
Background and aims Recently, several randomized trials have shown that patients with
multivessel disease (MVD) often pursue complete revascularization during percutaneous …

[HTML][HTML] Fractional flow reserve use in coronary artery revascularization: A systematic review and meta-analysis

JS Sánchez, JIF Pasos, JM Solé, B Hussain, S Kumar… - Iscience, 2023 - cell.com
Fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) is
recommended in revascularization guidelines for intermediate lesions. However, recent …

Clinical use of physiological lesion assessment using pressure guidewires: an expert consensus document of the Japanese association of cardiovascular intervention …

Y Kawase, H Matsuo, S Kuramitsu, Y Shiono… - Cardiovascular …, 2022 - Springer
Fractional flow reserve and instantaneous wave-free ratio are widely accepted and
recommended in Western and Japanese guidelines for appropriate percutaneous coronary …

The role of physiology in the contemporary management of coronary artery disease

F Rubino, G Pompei, S Brugaletta, C Collet… - Heart, 2024 - heart.bmj.com
Coronary physiology assessment, including epicardial and microvascular investigations, is a
fundamental tool in the contemporary management of patients with coronary artery disease …